Osteoporosis and the aging male

References

• Raisz L. G. The osteoporosis revolution. Ann Intern Med 1997; 126: 458–62
   PubMed Web of Science ®Google Scholar
• Ebeling P. R. Osteoporosis in men—new insights into aetiology, pathogenesis, prevention and management. Drugs Aging 1998; 13: 421–34
   PubMedGoogle Scholar
• Melton L. J., Atkinson E. J., O'Connor M. K., O'Fallon W. M., Riggs B. L. Bone density and fracture risk in men. J Bone Miner Res 1998; 13: 1915–23
   PubMed Web of Science ®Google Scholar
• Looker A. C., Orwoll E. S., Johnston C. C., Jr, Lindsay R. L., Warmer H. W., Dunn W. L., et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 1997; 12: 1761–8
   PubMed Web of Science ®Google Scholar
• Mussolino M. E., Looker A. C., Madans J. H., Langlois J. A., Orwoll E. S. Risk factors for hip fracture in white men: the NHANES I Epidemiologic Follow‐up Study. J Bone Miner Res 1998; 13: 918–24
   PubMed Web of Science ®Google Scholar
• Poor G., Atkinson E. J., O'Fallon W. M., Melton L. J. I. I. I. Determinants of reduced survival following hip fractures in men. Clin Orthop 1995; 319: 260–5
   PubMed Web of Science ®Google Scholar
• Poor G., Atkinson E. J., O'Fallon W. M., Melton L. J. I. I. I. Predictors of hip fractures in elderly men. J Bone Miner Res 1995; 10: 1900–7
   PubMed Web of Science ®Google Scholar
• Center J. R., Nguyen T. V., Schneider D., Sambrook P. N., Eisman J. A. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999; 353: 878–82
   PubMed Web of Science ®Google Scholar
• Hinton R. Y., Lennox D. W., Ebert F. R., Jacobsen S. J., Smith G. S. Relative rates of fracture of the hip in the United States. Geographic, sex, and age variations. J Bone Joint Surg Am 1995; 77: 695–702
   Google Scholar
• Seeman E. The structural basis of bone fragility in men. Bone 1999; 25: 143–7
   PubMed Web of Science ®Google Scholar
• Orwoll E. S. Osteoporosis in men. Endocrinol Metab Clin North Am 1998; 27: 349–67
   PubMed Web of Science ®Google Scholar
• Scane A. C., Francis R. M., Sutcliffe A. M., Francis M. J. D., Rawlings D. J., Chappie C. L. Case—control study of the pathogenesis of sequelae of symtomatic vertebral fractures in men. Osteoporos Int 1999; 9: 91–7
   PubMed Web of Science ®Google Scholar
• Burger H., de Laet C. E., van Daele P. L., Weel A. E., Witteman J. C., Hofman A., et al. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am J Epidemiol 1998; 147: 871–9
   PubMed Web of Science ®Google Scholar
• Hoidrop S., Gronbaek M., Gottschau A., Lauritzen J. B., Schroll M. Alcohol intake, beverage preference, and risk of hip fracture in men and women. Am J Epidemiol 1999; 149: 993–1001
   Google Scholar
• Cohen‐Solal M. E., Baudoin C., Omouri M., Kuntz D., De Vernejoul M. C. Bone mass in middle‐aged osteoporotic men and their relatives: familial effect. J Bone Miner Res 1998; 13: 1901–14
   Google Scholar
• Fayayerji D., Eastell R. Age‐related changes in bone turnover in men. J Bone Miner Res 1999; 14: 1201–10
   Google Scholar
• Ongphiphadhanakul B., Rajatanavin R., Chanprasertyothin S., Piaseu N., Chailurkit L. Serum oestradiol and oestrogen‐receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol 1998; 49: 803–9
   PubMed Web of Science ®Google Scholar
• Orwoll E. S., Bell N. H., Nanes M. S., Flessland K. A., Pettinger M. G., Mallinak N. J., et al. Collagen N‐telopeptide excretion in men: the effects of age and intrasubject variability. J Clin Endocrinol Metab 1998; 83: 3930–5
   PubMed Web of Science ®Google Scholar
• Khosla S., Melton L. J. I. I. I., Atkinson E. J., O'Fallon W. M., Klee G. G., Riggs B. L. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1998; 83: 2266–74
   PubMed Web of Science ®Google Scholar
• Kenny A. M., Gallagher J. C., Prestwood K. M., Gruman C. A., Raisz L. G. Bone density, bone turnover, and hormone levels in men over age 75. J Gerontol 1998; 53: M419–25
   Google Scholar
• Lips P., Courpron P., Meunier P. J. Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res 1978; 26: 13–17
   PubMedGoogle Scholar
• Clarke B., Ebeling P. R., Jones J. D., Wahner H. W., O'Fallon W. M., Riggs B. L., et al. Changes in quantitative bone histomorphometry in aging healthy men. J Clin Endocrinol Metab 1996; 81: 2264–70
   PubMed Web of Science ®Google Scholar
• Katznelson L. Therapeutic role of androgens in the treatment of osteoporosis in men. Baillieres Clin Endocrinol Metab 1998; 12: 453–70
   Google Scholar
• Maillefert J. F., Sibilia J., Michel F., Saussine C., Javier R. M., Tavernier C. Bone mineral density in men treated with synthetic gonadotropin‐releasing hormone agonist for prostatic carcinoma. J Urol 1999; 161: 1219–22
   PubMed Web of Science ®Google Scholar
• Diamond T., Campbell J., Bryant C., Lynch W. The effect of combined androgen blockage in bone turnover and bone mineral densities in men treated for prostrate carcinoma. Cancer 1998; 83: 1561–6
   PubMed Web of Science ®Google Scholar
• Hofbauer L. C., Khosla S. Androgen effects on bone metabolism: recent progress and controversies. Eur J Endocrinol 1999; 140: 271–86
   PubMed Web of Science ®Google Scholar
• Center J. R., Nhuyen T. V., Sambrook P. N., Eisman J. A. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 1999; 84: 3626–35
   PubMed Web of Science ®Google Scholar
• Bilezikian J. P., Morishima A., Bell J., Grumbach M. M. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 1998; 339: 599–603
   PubMed Web of Science ®Google Scholar
• Gillberg P., Johansson A. G., Ljunghall S. Decreased estradiol levels and free androgen index and elevated sex hormone‐binding globulin levels in male idiopathic osteoporosis. Calcif Tissue Int 1999; 64: 209–13
   PubMedGoogle Scholar
• Anderson F. H., Francis R. M., Peaston R. T., Wastell H. J. Androgen supplementation in eugonadal men with osteoporosis: effects of six month's treatment on makers of bone formation and resorption. J Bone Miner Res 1997; 12: 472–8
   PubMed Web of Science ®Google Scholar
• Kurland E. S., Chan F. K., Rosen C. J., Bilezikian J. P. Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin‐like growth factor‐I. J Clin Endocrinol Metab 1998; 83: 2576–9
   PubMedGoogle Scholar
• Dennison E., Hindmarsh P., Fall C., Kellingray S., Barker D., Phillips D., et al. Profiles of endogenous circulating Cortisol and bone mineral density in healthy elderly men. J Clin Endocrinol Metab 1999; 84: 3058–63
   PubMedGoogle Scholar
• Adams J. S., Song C. F., Kantorovich V. Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide. Ann Intern Med 1999; 130: 658–60
   Google Scholar
• Kroger H., Lunt M., Reeve J., Dequeker J., Adams J. E., Birkenhager J. C., et al. Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: the European quantitation of osteoporosis study. Calcif Tissue Int 1999; 64: 191–9
   Google Scholar
• Legrand E., Chappard D., Pascaretti C., Duquenne M., Rondeau C., Simon Y., et al. Bone mineral density and vertebral fractures in men. Osteoporos Int 1999; 10: 265–70
   PubMedGoogle Scholar
• Snyder P. J., Peachey H., Hannoush P., Berlin J. A., Loh L., Holmes J. H., et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 1966–72
   PubMed Web of Science ®Google Scholar
• Slovik D. M., Rosenthal D. I., Doppelt S. H., Potts J. T., Jr, Daly M. A., Campbell J. A., et al. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25 dihydroxyvitamin D. J Bone Miner Res 1986; 1: 377–81
   PubMed Web of Science ®Google Scholar
• Ringe J. D., Dorst A., Kipshoven C., Rovati L. C., Setnikar I. Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low‐dose intermittent monofluorophosphate. Osteoporos Int 1998; 8: 47–52
   PubMed Web of Science ®Google Scholar